Concord Biotech Limited (NSE:CONCORDBIO)

Concord Biotech Revenue

In the fiscal year ending March 31, 2025, Concord Biotech had annual revenue of 12.00B INR with 18.01% growth. Concord Biotech had revenue of 4.30B in the quarter ending March 31, 2025, with 34.77% growth.

• Revenue: 12.00B
• Revenue Growth: +18.01%
• P/S Ratio: 15.90
• Revenue / Employee: 8.72M
• Employees: 1,377
• Market Cap: 190.77B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	12.00B	1.83B	18.01%
Mar 31, 2024	10.17B	1.64B	19.20%
Mar 31, 2023	8.53B	1.40B	19.67%
Mar 31, 2022	7.13B	959.91M	15.56%
Mar 31, 2021	6.17B	1.05B	20.42%